GlassScriptPhysician profile
Jean P Font
NPI 1316135320
$5,786.35
in general payments reported to CMS, 2019-2025
14 companies · $856 in 2025
The $856 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,239 · 2020: $50.25 · 2021: $2,143 · 2022: $253 · 2023: $96.58 · 2024: $149 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,087.10 | 2019-2025 | Scopis Ent |
| Abbott Laboratories | $623.26 | 2025 | Freestyle Libre 3 |
| Optinose US, INC. | $463.92 | 2019-2025 | |
| Glaxosmithkline, LLC. | $175.56 | 2023-2025 | Arexvy, Nucala |
| Baxter Healthcare | $122.45 | 2022 | |
| Alk-Abello, INC | $93.99 | 2019 | |
| Kaleo, INC. | $57.79 | 2019-2021 | |
| Boston Scientific Corporation | $35.78 | 2019 | |
| Smith+Nephew, INC. | $31.25 | 2019 | |
| Merck Sharp & Dohme LLC | $24.01 | 2023 | |
| Sanara Medtech INC. | $21.67 | 2025 | Celleraterx |
| Phadia US INC. | $17.13 | 2019 | |
| Aerin Medical INC. | $16.39 | 2022 | |
| Hologic Sales and Service, LLC | $16.05 | 2023 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Font listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.